A life sciences company has sold off part of its business that includes a Morrisville facility with hundreds of workers.

CTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.

Catalent provides contract manufacturing services and performs fill-finish work, which involves the sterile filling and ...

Sen. Elizabeth Warren urges FTC to scrutinize Novo Nordisk's $16.5 billion acquisition of Catalent over concerns of increased ...

Catalent (NYSE:CTLT) is selling its oral solids development and small-scale manufacturing facility in Somerset, New Jersey to ...

U.S. Senator Elizabeth Warren has asked antitrust regulators to scrutinize a $16.5 billion deal in which Novo Nordisk's ...

The site also serves as an oral solids development and small-scale manufacturing facility for the pharmaceutical company, ...

Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...

J&J beat expectations this week to launch the Q3 earnings season; a study about children treated with bluebird bio’s Skysona ...

Shares of Catalent, Inc. (NYSE:CTLT – Get Free Report) have received an average recommendation of “Hold” from the eight ratings firms that are covering the company, Marketbeat Ratings reports. Eight ...

Catalent entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in ...

Senator Elizabeth Warren told the Federal Trade Commission that the acquisition of contract manufacturer Catalent could ...